EP 1446384 A1 20040818 - POLYMORPHOUS FORM OF RIMONABANT, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Title (en)
POLYMORPHOUS FORM OF RIMONABANT, PREPARATION METHOD AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
Title (de)
POLYMORPHE FORM VON RIMONABANT, VERFAHREN ZU IHRER HERSTELLUNG UND DIESE ENTHALTENDE ARZNEIMITTEL
Title (fr)
FORME POLYMORPHE DU RIMONABANT, SON PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES EN CONTENANT
Publication
Application
Priority
- FR 0203765 W 20021104
- FR 0114579 A 20011108
Abstract (en)
[origin: WO03040105A1] The invention concerns a novel crystalline polymorph of rimonabant, its preparation method and pharmaceutical compositions containing said novel polymorph.
IPC 1-7
IPC 8 full level
A61K 31/4155 (2006.01); A61K 31/455 (2006.01); A61P 35/00 (2006.01); A61P 43/00 (2006.01); C07D 231/14 (2006.01)
CPC (source: EP KR US)
A61P 3/04 (2018.01 - EP); A61P 35/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07D 231/14 (2013.01 - EP US); C07D 401/10 (2013.01 - KR)
Citation (examination)
BAUER M: "LA CRISTALLISATION DES MOLECULES CONSEQUENCES EN TERMES DE POLYMORPHISME ET FACIES APPLIQUEES AU DOMAINE PHARMACEUTIQUE CONCEPTS DE BASE", SCIENCES TECHNIQUES ET PRATIQUES STP PHARMA PRATIQUES, PARIS, FR, vol. 13, no. 2, 1 January 2003 (2003-01-01), pages 47 - 61, XP008141685, ISSN: 1157-1497
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
DOCDB simple family (publication)
WO 03040105 A1 20030515; AP 1830 A 20080222; AP 2004003024 A0 20040630; AR 037253 A1 20041103; AU 2002350869 B2 20070726; BR 0213931 A 20040908; CA 2464145 A1 20030515; CN 100412063 C 20080820; CN 1582278 A 20050216; CO 5580827 A2 20051130; CR 7333 A 20080923; EA 006771 B1 20060428; EA 200400491 A1 20041230; EC SP045088 A 20040628; EP 1446384 A1 20040818; FR 2831883 A1 20030509; FR 2831883 B1 20040723; GE P20063894 B 20060810; HR P20040403 A2 20040831; HU P0402043 A2 20050128; HU P0402043 A3 20090728; IL 161533 A0 20040927; IL 161533 A 20100531; IS 7226 A 20040419; JP 2005508383 A 20050331; JP 2009035547 A 20090219; JP 4181994 B2 20081119; JP 4931874 B2 20120516; KR 20050043774 A 20050511; KR 20090089485 A 20090821; MA 27080 A1 20041220; ME P21908 A 20100610; MX PA04004394 A 20040811; NO 20041879 D0 20040507; NO 20041879 L 20040608; NO 326648 B1 20090126; NZ 532369 A 20051028; OA 12721 A 20060627; PL 369372 A1 20050418; RS 36904 A 20061027; TN SN04079 A1 20060601; TW 200302824 A 20030816; UA 76776 C2 20060915; US 2005043356 A1 20050224; US 2010190827 A1 20100729; ZA 200402999 B 20050420
DOCDB simple family (application)
FR 0203765 W 20021104; AP 2004003024 A 20021104; AR P020104228 A 20021106; AU 2002350869 A 20021104; BR 0213931 A 20021104; CA 2464145 A 20021104; CN 02821968 A 20021104; CO 04040840 A 20040504; CR 7333 A 20040504; EA 200400491 A 20021104; EC SP045088 A 20040427; EP 02785580 A 20021104; FR 0114579 A 20011108; GE AP2002005606 A 20021104; HR P20040403 A 20040506; HU P0402043 A 20021104; IL 16153302 A 20021104; IL 16153304 A 20040420; IS 7226 A 20040419; JP 2003542151 A 20021104; JP 2008181474 A 20080711; KR 20047006969 A 20040507; KR 20097016373 A 20021104; MA 27659 A 20040428; ME P21908 A 20021104; MX PA04004394 A 20021104; NO 20041879 A 20040507; NZ 53236902 A 20021104; OA 1200400131 A 20021104; PL 36937202 A 20021104; TN SN04079 A 20040507; TW 91132763 A 20021107; UA 2004402974 A 20021104; US 25970108 A 20081028; US 49421104 A 20041012; YU P36904 A 20021104; ZA 200402999 A 20040420